Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

CONSHOHOCKEN, Pa., February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC ...

James Cleary; Executive Vice President and Chief Financial Officer; Cencora Inc Thank you ... in a high-growth pharmaceutical-centric segment building on our services for our customers and ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients Cencora, a global healthcare company, has significantly expanded the number and ...

James Cleary; Executive Vice President and Chief Financial Officer; Cencora Inc Thank you. Good morning ... our strategy and growth by expanding our leadership in specialty in a high-growth ...